Heron Therapeutics
HRTX • NASDAQ
Heron Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Craig Alexander Collard, with a market cap of $192.3M.
Market Cap$192.3M
Employees126.0
CEOCraig Alexander Collard
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Heron Therapeutics FAQ
Common questions about Heron Therapeutics
Heron Therapeutics is scheduled to report earnings for Q1 2026 on May 5, 2026 before market open. Analysts estimate revenue of $38.4M.
Heron Therapeutics has approximately 126 employees.